يعرض 1 - 10 نتائج من 12 نتيجة بحث عن '"Cyril Garrouste"', وقت الاستعلام: 1.06s تنقيح النتائج
  1. 1

    المصدر: American Journal of Transplantation. 21:3021-3033

  2. 2

    المساهمون: Pediatric surgery, Amsterdam Reproduction & Development (AR&D)

    المصدر: Pottel, H, Björk, J, Courbebaisse, M, Couzi, L, Ebert, N, Eriksen, B O, Dalton, R N, Dubourg, L, Gaillard, F, Garrouste, C, Grubb, A, Jacquemont, L, Hansson, M, Kamar, N, Lamb, E J, Legendre, C, Littmann, K, Mariat, C, Melsom, T, Rostaing, L, Rule, A D, Schaeffner, E, Sundin, P-O, Turner, S, Bökenkamp, A, Berg, U, Åsling-Monemi, K, Selistre, L, Åkesson, A, Larsson, A, Nyman, U & Delanaye, P 2021, ' Development and Validation of a Modified Full Age Spectrum Creatinine-Based Equation to Estimate Glomerular Filtration Rate : A Cross-sectional Analysis of Pooled Data ', Annals of Internal Medicine, vol. 174, no. 2, pp. 183-191 . https://doi.org/10.7326/M20-4366
    Annals of Internal Medicine, 174(2), 183-191. American College of Physicians

  3. 3

    المساهمون: Barbour T., Scully M., Ariceta G., Cataland S., Garlo K., Heyne N., Luque Y., Menne J., Miyakawa Y., Yoon S.-S., Kavanagh D., Babu S., Broeders N., Lietar N., Brown F., Campbell P., Campistol J.M., Chowdhury P., Kasimatis T., Cirami L., Caroti L., Antognoli G., Delmas Y., Dobronravov V., Gaeckler A., Garrouste C., Greenwood G., Griffin S., Huang C.-C., Chen I.-R., Huang S., Kim J.S., La Manna G., Le Quintrec M., Jeantet G., Fumie I., Rondeau E., Haller H., Morelle J., Goffin E., Muhlfeld A., Nagaraj S., Arepally G., Oh D., Okumi M., Terente M.P., Provot F., Schonermarck U., Fischereder M., Terrada N.R., Seitz-Polski B., Favre G., Boyer-Suavet S., Vinogradova M., Kirsanova T., Wong E.K.S., Institut Català de la Salut, [Barbour T] Kidney Care, The Royal Melbourne Hospital, Melbourne, Australia. [Scully M] Department of Haematology, University College London Hospitals, London, UK. [Ariceta G] Servei de Nefrologia Pediàtrica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Cataland S] Division of Hematology, The Ohio State University Medical Center, Columbus, Ohio, USA. [Garlo K] Clinical Development, Alexion Pharmaceuticals, Inc., Boston, Massachusetts, USA. [Heyne N] Section of Nephrology and Hypertension, Tübingen University Hospital, Tübingen, Germany, Vall d'Hebron Barcelona Hospital Campus, UCL - SSS/IREC/NEFR - Pôle de Néphrologie, UCL - (SLuc) Service de néphrologie, The Royal Melbourne Hospital, University College London Hospitals (UCLH), Vall d'Hebron University Hospital [Barcelona], Ohio State University [Columbus] (OSU), Universitätsklinikum Tübingen - University Hospital of Tübingen, Eberhard Karls Universität Tübingen = Eberhard Karls University of Tuebingen, Sorbonne Université - Faculté de Médecine (SU FM), Sorbonne Université (SU), Seoul National University Hospital, Newcastle University [Newcastle]

    المصدر: Scientia
    Kidney international reports, Vol. 6, no.6, p. 1603-1613 (2021)
    Kidney International Reports
    Kidney International Reports, Elsevier, 2021, 6 (6), pp.1603-1613. ⟨10.1016/j.ekir.2021.03.884⟩
    Kidney International Reports, Vol 6, Iss 6, Pp 1603-1613 (2021)

    مصطلحات موضوعية: medicine.medical_specialty, Thrombotic microangiopathy, [SDV]Life Sciences [q-bio], Hemic and Lymphatic Diseases::Hematologic Diseases::Anemia::Anemia, Hemolytic::Hemolytic-Uremic Syndrome::Hemic and Lymphatic Diseases::Hematologic Diseases::Atypical Hemolytic Uremic Syndrome [DISEASES], 030232 urology & nephrology, Renal function, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], 030204 cardiovascular system & hematology, Other subheadings::Other subheadings::/drug therapy [Other subheadings], 03 medical and health sciences, 0302 clinical medicine, afecciones patológicas, signos y síntomas::procesos patológicos::atributos de la enfermedad::enfermedades raras [ENFERMEDADES], Clinical Research, Internal medicine, Atypical hemolytic uremic syndrome, Medicine, complement, Adverse effect, Complement component 5, business.industry, Pathological Conditions, Signs and Symptoms::Pathologic Processes::Disease Attributes::Rare Diseases [DISEASES], atypical hemolytic uremic syndrome, Acute kidney injury, diagnóstico::pronóstico::resultado del tratamiento [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], medicine.disease, Diagnosis::Prognosis::Treatment Outcome [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], ravulizumab, Diseases of the genitourinary system. Urology, 3. Good health, enfermedades hematológicas y linfáticas::enfermedades hematológicas::anemia::anemia hemolítica::síndrome hemolítico-urémico::enfermedades hematológicas y linfáticas::enfermedades hematológicas::síndrome hemolítico urémico atípico [ENFERMEDADES], kidney failure, thrombotic microangiopathy, Clinical trial, Nephrology, Avaluació de resultats (Assistència sanitària), hemolytic uremic syndrome, RC870-923, Síndrome hemolíticourèmica - Tractament, Malalties rares, business, Kidney disease

    وصف الملف: ELETTRONICO; application/pdf

  4. 4

    المصدر: Clinical Kidney Journal

    وصف الملف: Electronic-eCollection

  5. 5

    المساهمون: Unité de Nutrition Humaine (UNH), Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE)-Université Clermont Auvergne (UCA), CHU Gabriel Montpied [Clermont-Ferrand], CHU Clermont-Ferrand, Centre Hospitalier Emile Roux [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Service de Néphrologie - Hémodialyses [CHU Clermont-Ferrand], Pôle RHEUNNIRS [CHU Clermont-Ferrand], CHU Clermont-Ferrand-CHU Clermont-Ferrand-CHU Gabriel Montpied [Clermont-Ferrand], CHU Clermont-Ferrand-CHU Clermont-Ferrand, Dept Clin Nutr, Unité de Biostatistiques [CHU Clermont-Ferrand], Direction de la recherche clinique et de l’innovation [CHU Clermont-Ferrand] (DRCI), Université Clermont Auvergne [2017-2020] (UCA [2017-2020])-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Unité de Biostatistiques, Direction de la Recherche Clinique (DRCI)

    المصدر: PLoS ONE, Vol 15, Iss 7, p e0236948 (2020)
    PLoS ONE
    PLoS ONE, 2020, 15 (7), ⟨10.1371/journal.pone.0236948⟩
    PLoS ONE, Public Library of Science, 2020, 15 (7), pp.e0236948. ⟨10.1371/journal.pone.0236948⟩
    PLoS ONE, 2020, 15 (7), pp.e0236948. ⟨10.1371/journal.pone.0236948⟩

  6. 6

    المساهمون: Service de médecine interne [CHU Pitié-Salpétrière], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU), Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO), Biologie de l'Os et du Cartilage : Régulations et Ciblages Thérapeutiques (BIOSCAR (UMR_S_1132 / U1132)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité), Service de Rhumatologie [CHU Lariboisière], Hôpital Lariboisière-Fernand-Widal [APHP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Département de Néphrologie [CHU Necker], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Necker - Enfants Malades [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), CHU Pontchaillou [Rennes], Service de Rhumatologie [CHU Bicêtre], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Bicêtre, CHRU Brest - Service de Nephrologie (CHU - BREST - Nephrologie), Centre Hospitalier Régional Universitaire de Brest (CHRU Brest), CHU Henri Mondor, CHU Amiens-Picardie, Mécanismes physiologiques et conséquences des calcifications cardiovasculaires: rôle des remodelages cardiovasculaires et osseux, Université de Picardie Jules Verne (UPJV)-Institut National de la Santé et de la Recherche Médicale (INSERM), Mécanismes physiopathologiques et conséquences des calcifications vasculaires - UR UPJV 7517 (MP3CV), Université de Picardie Jules Verne (UPJV)-CHU Amiens-Picardie, Centre hospitalier universitaire de Nantes (CHU Nantes), CHU Clermont-Ferrand, Hopital Saint-Louis [AP-HP] (AP-HP), Service de Néphrologie-Dialyse-Transplantation rénale [CHU Caen], Université de Caen Normandie (UNICAEN), Normandie Université (NU)-Normandie Université (NU)-CHU Caen, Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN)-Tumorothèque de Caen Basse-Normandie (TCBN), Centre Hospitalier Universitaire de Reims (CHU Reims), Centre d'Investigation Clinique de Besançon (Inserm CIC 1431), Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Etablissement français du sang [Bourgogne-Franche-Comté] (EFS [Bourgogne-Franche-Comté])-Université de Franche-Comté (UFC), Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC), Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon), Département de Pathologie [CHU Necker], Université Sorbonne Paris Cité (USPC)-CHU Necker - Enfants Malades [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Cité (UPCité), Gestionnaire, Hal Sorbonne Université, CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Paris (UP), CHU Necker - Enfants Malades [AP-HP], Université de Franche-Comté (UFC), Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon)-Etablissement français du sang [Bourgogne-Franche-Comté] (EFS [Bourgogne-Franche-Comté]), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université de Paris (UP)

    المصدر: Kidney International Reports
    Kidney International Reports, 2020, 5 (6), pp.813-820. ⟨10.1016/j.ekir.2020.03.012⟩
    Kidney Int Rep, vol. 5, no. 6, pp. 813-820
    Kidney International Reports, Elsevier, 2020, 5 (6), pp.813-820. ⟨10.1016/j.ekir.2020.03.012⟩

    وصف الملف: application/pdf

  7. 7

    المساهمون: Service de Cardiologie Maladies Vasculaires [CHU Clermont-Ferrand], CHU Gabriel Montpied [Clermont-Ferrand], CHU Clermont-Ferrand-CHU Clermont-Ferrand, Service de Néphrologie - Hémodialyses [CHU Clermont-Ferrand], Pôle RHEUNNIRS [CHU Clermont-Ferrand], CHU Clermont-Ferrand-CHU Clermont-Ferrand-CHU Gabriel Montpied [Clermont-Ferrand], Unité de Biostatistiques [CHU Clermont-Ferrand], Direction de la recherche clinique et de l’innovation [CHU Clermont-Ferrand] (DRCI), Service de Chrirurgie Cardio Vasculaire [CHU Clermont-Ferrand], Institut Pascal (IP), SIGMA Clermont (SIGMA Clermont)-Université Clermont Auvergne [2017-2020] (UCA [2017-2020])-Centre National de la Recherche Scientifique (CNRS)

    المصدر: Archives of cardiovascular diseases
    Archives of cardiovascular diseases, Elsevier/French Society of Cardiology, 2019, 112, pp.162-170. ⟨10.1016/j.acvd.2018.10.003⟩
    Archives of cardiovascular diseases, 2019, 112, pp.162-170. ⟨10.1016/j.acvd.2018.10.003⟩

  8. 8

    المصدر: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, vol 19, iss 2
    American Journal of Transplantation
    Eder, M, Schwarz, C, Kammer, M, Jacobsen, N, Stavroula, M L, Cowan, M J, Chongkrairatanakul, T, Gaston, R, Ravanan, R, Ishida, H, Bachmann, A, Alvarez, S, Koch, M, Garrouste, C, Duffner, U A, Cullis, B, Schaap, N, Medinger, M, Sørensen, S S, Dauber, E-M, Böhmig, G, Regele, H, Berlakovich, G A, Wekerle, T & Oberbauer, R 2019, ' Allograft and patient survival after sequential HSCT and kidney transplantation from the same donor-A multicenter analysis ', American Journal of Transplantation, vol. 19, no. 2, pp. 475-487 . https://doi.org/10.1111/ajt.14970
    American Journal of Transplantation, 19, 475-487
    American Journal of Transplantation, 19, 2, pp. 475-487

    مصطلحات موضوعية: Male, Kidney Disease, Cancer development and immune defence Radboud Institute for Molecular Life Sciences [Radboudumc 2], medicine.medical_treatment, kidney transplantation/nephrology, tolerance: clinical, Hematopoietic stem cell transplantation, 030230 surgery, Regenerative Medicine, Medical and Health Sciences, Kidney Failure, chemistry.chemical_compound, 0302 clinical medicine, Risk Factors, Living Donors, Immunology and Allergy, Pharmacology (medical), Chronic, Kidney transplantation, dysfunction, Graft Survival, Hematopoietic Stem Cell Transplantation, Immunosuppression, Clinical Science, Middle Aged, Prognosis, Allografts, Combined Modality Therapy, practice, Survival Rate, Tolerance induction, surgical procedures, operative, Original Article, 030211 gastroenterology & hepatology, Female, 6.4 Surgery, Immunosuppressive Agents, Homologous, Adult, medicine.medical_specialty, bone marrow, Adolescent, kidney (allograft) function, Renal and urogenital, Urology, nephrology, Renal function, kidney transplantation, kidney (allograft) function/dysfunction, clinical research/practice, 03 medical and health sciences, Young Adult, All institutes and research themes of the Radboud University Medical Center, medicine, Transplantation, Homologous, Humans, bone marrow/hematopoietic stem cell transplantation, Dialysis, Creatinine, Transplantation, business.industry, Evaluation of treatments and therapeutic interventions, Organ Transplantation, Stem Cell Research, medicine.disease, Kidney Transplantation, chemistry, clinical research, Case-Control Studies, Kidney Failure, Chronic, clinical [tolerance], Surgery, ORIGINAL ARTICLES, business, Follow-Up Studies

    وصف الملف: application/pdf

  9. 9

    المساهمون: Unité de Nutrition Humaine (UNH), Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE)-Université Clermont Auvergne (UCA), CHU Gabriel Montpied [Clermont-Ferrand], CHU Clermont-Ferrand, Centre Hospitalier Jacques Lacarin, American University of Beirut Faculty of Medicine and Medical Center (AUB), Centre Hospitalier Emile Roux [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Direction de la recherche clinique et de l’innovation [CHU Clermont-Ferrand] (DRCI), Service de Néphrologie - Hémodialyses [CHU Clermont-Ferrand], Pôle RHEUNNIRS [CHU Clermont-Ferrand], CHU Clermont-Ferrand-CHU Clermont-Ferrand-CHU Gabriel Montpied [Clermont-Ferrand], CHU Clermont-Ferrand-CHU Clermont-Ferrand

    المصدر: Journal of Nephrology
    Journal of Nephrology, 2023, 31 (1), pp.147-155. ⟨10.1007/s40620-017-0449-z⟩

  10. 10